Skip to main content

Bryan Davies

Member for

2 years 6 months
Full name
Gary Chiang

Research that's Changing the World

Bryan Davies has contributed discoveries to the pressing issue of antibiotic resistance, a worldwide threat to human health. He has led work to harness peptides and small proteins—tiny but powerful biological molecules—to treat drug-resistant bacterial infections. His research has identified promising antibiotic candidates and developed new ways to precisely deliver these molecules where they’re needed in the body.

What Starts Here

As a professor in the Department of Molecular Biosciences, Davies holds the Lorene Morrow Kelley Professorship in Microbiology. He serves on the NIH Drug Discovery and Molecular Pharmacology review panel, acts as a consultant for healthcare and agriculture biotechnology companies and co-founded an antibiotic start-up company. His research has led to technologies and reagents now licensed by five private companies, highlighting both their scientific value and real-world potential as these partnerships help turn his discoveries into practical solutions. Additionally, Davies helped produce the critically acclaimed documentary film "Stumped" about one man's survival of a deadly bacterial infection and the growing perils of antibiotic resistance.

Beyond the Forty Acres

Emily Mallick, Ph.D. Invaio, Director, Project Management Office: "His work has the potential to help industry accelerate the leap to nature-positive agriculture, solve challenging problems like Citrus greening (also known as Huanglongbing or HLB), a devastating bacterial disease for which there is no current solution.... Techniques pioneered in Dr. Davies' lab such as Surface Localized Antimicrobial Display (SLAY), can be utilized to screen upwards of a million diverse peptides at once to identify effective candidates to fight HLB."

Surface Localized Antimicrobial displaY (SLAY)
The Davies Lab developed a new platform to help find the next generation of antibiotics. Surface Localized Antimicrobial displaY (SLAY) allows screening of unlimited numbers of peptides of any length, composition, and structure in a single tube for antimicrobial activity, increasing the chances of finding a good lead antibiotic.

 

Image
Bryan Davies
ID
3